GSK-1322888

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameGSK-1322888
Drug Alias Name1322888GSK-1322888
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMotilin receptor agonists
TargetsMotilin receptor
Therapy Area/IndicationsGastroparesis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsGastroparesis

Other Information

ATC CodeN/A
Related LinksN/A